News
Contact Us
TEL: +86-(0)917-3385926 3380951
FAX: +86-(0)917-3385946
MOB: 15191772732(Wechat) E-mail: sanli_sales@outlook.com
ADDRESS: Middle part of Taicheng Road, High-tech Development Zone, Baoji, Shaanxi
Company NewsYou are here: Home > News > Company News
Medical surgical implants titanium alloy product quality standardization workshop held in Xi'an
Release date: 2014-4-26 21:57:54
April 26-27 , sponsored by the Chinese Society for Biomaterials and Biomedical Engineering Society of China , Northwest Institute for Nonferrous Metals ( Group ) Co's " surgical implant titanium alloy product quality standardization Seminar" held in Xi'an. Leaders from the State Drug Administration food , Shaanxi Province Food and Drug Administration and the Beijing , Tianjin, Shaanxi Yixie inspection agency belongs , experts, and learn related biomaterials and medical devices, associations, alliances and domestic well-known hospitals, universities and companies medical experts , materials specialists and entrepreneurs attended the seminar. Second Affiliated Hospital of Xi'an Jiaotong University Professor He Xijing , an Affiliated Professor Lv Yi attendees and speakers . Director of the State Food and Drug Administration Shixin Li and Professor Tian Weidong and other four representatives of invited keynote speakers, delegates reached consensus after full discussion :
To effectively ensure the quality of titanium medical products should be in the " surgical implants of titanium and titanium alloy with a national standard " (GB/T13810-2007) , based on recommendations by the Northwest Nonferrous Metal Research Institute led the preparation of " medical titanium production technical specifications " , the relevant government departments and industry associations for guidance , requiring medical titanium production enterprises to increase the amount of titanium raw materials before production of medical products must pass the relevant quality certification ( accreditation of production ) , the proposed National Pharmaceutical Administration Omo wide range of medical titanium alloy surgical implant strict supervision of major raw materials , production of medical devices from the source control, so as to continuously improve the quality of domestic medical devices. Meanwhile, the suggestion of biological materials , medical equipment production enterprises and large and medium-sized hospitals and relevant government departments and work closely with industry associations , collective action , early completion of titanium alloy surgical implant product quality standardization of construction , supervision and implemented.
Previous: new medical Ti-25Nb-10Ta-1Zr-0.2Fe titanium cell toxicity studies